The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease : an interview with David A Schwartz, 13 June 2007

التفاصيل البيبلوغرافية
العنوان:	The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease : an interview with David A Schwartz, 13 June 2007
المؤلفون:	Schwartz, David A
المصدر:	Biologics, 2008; v.2 n.1:p.125-128
الوصول الحر:	https://ndhadeliver.natlib.govt.nz/delivery/DeliveryManagerServlet?dps_pid=FL1059246Test
قاعدة البيانات:	Index New Zealand

الوصف
تدمد:	11775475 11775491